BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marć MA, Domínguez-Álvarez E, Gamazo C. Nucleic acid vaccination strategies against infectious diseases. Expert Opin Drug Deliv 2015;12:1851-65. [PMID: 26365499 DOI: 10.1517/17425247.2015.1077559] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Loh FK, Nathan S, Chow SC, Fang CM. Vaccination challenges and strategies against long-lived Toxoplasma gondii. Vaccine 2019;37:3989-4000. [PMID: 31186188 DOI: 10.1016/j.vaccine.2019.05.083] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Gershoni JM. B-cell restriction - an alternative piece to the puzzle. Hum Vaccin Immunother 2019;15:2044-9. [PMID: 30945969 DOI: 10.1080/21645515.2019.1600989] [Reference Citation Analysis]
3 Talotta R. Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to "potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases". Clin Immunol 2021;224:108665. [PMID: 33429060 DOI: 10.1016/j.clim.2021.108665] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 24.0] [Reference Citation Analysis]
4 Maleki A, Look-Why S, Manhapra A, Foster CS. COVID-19 Recombinant mRNA Vaccines and Serious Ocular Inflammatory Side Effects: Real or Coincidence? J Ophthalmic Vis Res 2021;16:490-501. [PMID: 34394876 DOI: 10.18502/jovr.v16i3.9443] [Reference Citation Analysis]
5 Qin F, Xia F, Chen H, Cui B, Feng Y, Zhang P, Chen J, Luo M. A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications. Front Cell Dev Biol 2021;9:633776. [PMID: 34113610 DOI: 10.3389/fcell.2021.633776] [Reference Citation Analysis]
6 Hayashi H, Sun J, Yanagida Y, Otera T, Kubota-koketsu R, Shioda T, Ono C, Matsuura Y, Arase H, Yoshida S, Nakamaru R, Ju N, Ide R, Tenma A, Kawabata S, Ehara T, Sakaguchi M, Tomioka H, Shimamura M, Okamoto S, Amaishi Y, Chono H, Mineno J, Komatsuno T, Saito Y, Rakugi H, Morishita R, Nakagami H. Preclinical study of a DNA vaccine targeting SARS-CoV-2. Current Research in Translational Medicine 2022. [DOI: 10.1016/j.retram.2022.103348] [Reference Citation Analysis]
7 Chen J, Chen L, Zhang H, Quan Y. Enhancing the antitumour-specific immunity of a lung DNA vaccine in vivo by fusion expression of MAGE-A3 and soluble PD-1. Biotechnology & Biotechnological Equipment 2017;31:1064-9. [DOI: 10.1080/13102818.2017.1343100] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]